DEA Gets an Earful About Telehealth Prescribing of Controlled Substances — Proposed in-person visit requirements raises concern for psychiatry groups
Should the Drug Enforcement Administration (DEA) require a prior in-person visit before allowing clinicians to prescribe controlled substances via telemedicine? That was one of the issues that DEA officials heard conflicting testimony on during a "listening session" opens in a new tab or window Tuesday.